Comparing Streamline Health Solutions (STRM) and China Cord Blood Corporation (CO)
Streamline Health Solutions (NASDAQ: STRM) and China Cord Blood Corporation (NYSE:CO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.
This is a breakdown of current ratings and recommmendations for Streamline Health Solutions and China Cord Blood Corporation, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Streamline Health Solutions||0||0||0||0||N/A|
|China Cord Blood Corporation||0||0||0||0||N/A|
Insider and Institutional Ownership
37.9% of Streamline Health Solutions shares are owned by institutional investors. Comparatively, 13.3% of China Cord Blood Corporation shares are owned by institutional investors. 26.1% of Streamline Health Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This table compares Streamline Health Solutions and China Cord Blood Corporation’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Streamline Health Solutions||-24.50%||-56.04%||-15.49%|
|China Cord Blood Corporation||22.07%||8.64%||3.50%|
Volatility and Risk
Streamline Health Solutions has a beta of 0.1, indicating that its stock price is 90% less volatile than the S&P 500. Comparatively, China Cord Blood Corporation has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.
Earnings and Valuation
This table compares Streamline Health Solutions and China Cord Blood Corporation’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Streamline Health Solutions||$24.86 million||1.33||-$3.83 million||($0.31)||-5.39|
|China Cord Blood Corporation||$124.21 million||10.34||$53.01 million||$0.29||39.00|
China Cord Blood Corporation has higher revenue and earnings than Streamline Health Solutions. Streamline Health Solutions is trading at a lower price-to-earnings ratio than China Cord Blood Corporation, indicating that it is currently the more affordable of the two stocks.
China Cord Blood Corporation beats Streamline Health Solutions on 8 of the 10 factors compared between the two stocks.
About Streamline Health Solutions
Streamline Health Solutions, Inc. is engaged in providing healthcare information technology through the licensing of its Electronic Health Information Management, Patient Financial, Coding and Clinical Documentation Improvement (CDI), and other Workflow software applications, and the use of such applications by software as a service. The Company also provides implementation and consulting services to complement its software solutions. The Company provides computer software-based solutions through its Looking Glass platform. The Company sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships. The Company’s software and services allow hospitals and integrated healthcare delivery systems in the United States and Canada to capture, store, manage, route, retrieve and process patient clinical, financial and other healthcare provider information.
About China Cord Blood Corporation
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.
Receive News & Ratings for Streamline Health Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.